Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carboplatin, Nab-Paclitaxel, and Bevacizumab in Metastatic Breast Cancer
NCT00654836Phase 2Completed
- Sponsor
- Loyola University Chicago
- Start
- Oct 2007
- Primary completion
- Feb 2012
- Modality
- Small Molecules, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel, bevacizumab in breast cancer, sponsored by Loyola University Chicago. Started Oct 2007; status: completed.
02
Drugs
paclitaxelbevacizumab
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00654836.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00654836.